Cercar

01/03/2023 Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus
Rodriguez-Calvo, R, Granado-Casas, M, de Oca, APM, Julian, MT, Domingo, M, Codina, P, Santiago-Vacas, E, Cediel, G, Julve, J, Rossell, J, Masana, L, Mauricio, D, Lupon, J, Bayes-Genis, A, Alonso, N. Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus. Antioxidants. 2023; 12(3)DOI:10.3390/antiox12030645. PMID:36978893. IF:6.000(Q1/2D).
01/03/2023 Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes
Giannella, A, Castelblanco, E, Zambon, CF, Basso, D, Hernandez, M, Ortega, E, Alonso, N, Mauricio, D, Avogaro, A, Ceolotto, G, Vigili de Kreutzenberg, S. Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. DIABETES CARE. 2023; 46(3)DOI:10.2337/dc22-1441. PMID:36577032. IF:14.800(Q1/1D).
01/03/2023 Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control
Julve, J, Genua, I, Quifer-Rada, P, Yanes, O, Barranco-Altirriba, M, Hernandez, M, Junza, A, Capellades, J, Granado-Casas, M, Alonso, N, Castelblanco, E, Mauricio, D. Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control. DIABETES RESEARCH AND CLINICAL PRACTICE. 2023; 197DOI:10.1016/j.diabres.2023.110578. PMID:36804334. IF:6.100(Q1/2D).
28/02/2023 Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study
Bundo, M, Vlacho, B, Llussa, J, Bobe, I, Aivar, M, Ciria, C, Martinez-Sanchez, A, Real, J, Mata-Cases, M, Cos, X, Doria, M, Viade, J, Franch-Nadal, J, Mauricio, D. Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study. Journal of Foot and Ankle Research. 2023; 16(1)DOI:10.1186/s13047-023-00602-6. PMID:36849888. IF:2.500(Q1/3D).
01/02/2023 Outcome of COVID-19 infection in people with diabetes mellitus or obesity in the primary care setting in Catalonia, Spain: A retrospective cohort study of the initial three waves
Mauricio, D, Vlacho, B, Ortega, E, Cos-Claramunt, X, Mata-Cases, M, Real, J, Fernandez-Camins, B, Franch-Nadal, J. Outcome of COVID-19 infection in people with diabetes mellitus or obesity in the primary care setting in Catalonia, Spain: A retrospective cohort study of the initial three waves. Primary Care Diabetes. 2023; 17(1)DOI:10.1016/j.pcd.2022.12.002. PMID:36528549. IF:2.600(Q1/3D).
01/01/2023 All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK
Ling S., Zaccardi F., Vlacho B., Li P., Gatius, JR, Mata-Cases M., Franch-Nadal J., Kosiborod M.N., Gillies C., Fenici P., Mauricio D., Shah B.R., Khunti K.. All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK. DIABETES OBESITY & METABOLISM. 2023; 25(1)DOI:10.1111/dom.14856. PMID:36056765. IF:5.400(Q1/2D).
01/01/2023 Type 2 Diabetes mellitus alters the cargo of (poly)phenol metabolome and the oxidative status in circulating lipoproteins
Reis A., Rocha S., Dias I.H., Costa R., Soares R., Sánchez-Quesada J.L., Perez A., de Freitas V.. Type 2 Diabetes mellitus alters the cargo of (poly)phenol metabolome and the oxidative status in circulating lipoproteins. Redox Biology. 2023; 59DOI:10.1016/j.redox.2022.102572. PMID:36516720. IF:10.700(Q1/1D).
01/01/2023 Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
Muller-Wieland, D, Freemantle, N, Bonadonna, RC, Mauquoi, C, Bigot, G, Bonnemaire, M, Gourdy, P, Mauricio, D. Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database. Diabetes Therapy. 2023; 14(2)DOI:10.1007/s13300-022-01356-3. PMID:36596946. IF:2.800(Q3/6D).
01/01/2023 Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project
Sánchez E., Sánchez M., López-Cano C., Bermúdez-López M., Valdivielso J.M., Farras-Salles, C, Pamplona R., Torres G., Mauricio D., Castro E., Fernández E., Lecube A.. Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project. Nutrients. 2023; 15(1)DOI:10.3390/nu15010203. PMID:36615860. IF:4.800(Q1/2D).
01/01/2023 Obesity and fertility. Position statement
Miñambres I., de Hollanda A., Vilarrasa N., Pellitero S., Rubio M.A., Flores L., Caixàs A., Lobo S., Martinez Salamanca J.I., Acevedo B., Moizé V., Andreu A., Escalada J.. Obesity and fertility. Position statement. Endocrinologia Diabetes y Nutricion. 2023; 70DOI:10.1016/j.endinu.2022.10.002. PMID:. IF:(Q/D).
01/01/2023 Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología
Pedro-Botet J., Barrios V., Sánchez-Margalet V., Tamargo J., Arrieta F., Gámez J.M., Gimeno-Orna J.A., Escobar C., Gómez-Doblas J.J., Pérez A.. Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología. Endocrinologia Diabetes y Nutricion. 2023; 70DOI:10.1016/j.endinu.2022.03.004. PMID:. IF:(Q/D).
01/01/2023 Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open-label, multinational, randomised, controlled, non-inferiority trial
Mathiesen E.R., Alibegovic A.C., Corcoy R., Dunne F., Feig D.S., Hod M., Jia T., Kalyanam B., Kar S., Kautzky-Willer A., Marchesini C., Rea R.D., Damm P.. Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open-label, multinational, randomised, controlled, non-inferiority trial. Lancet Diabetes & Endocrinology. 2023; 11(2)DOI:10.1016/S2213-8587(22)00307-2. PMID:36623517. IF:44.000(Q1/1D).
01/01/2023 Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study
Julián M.T., Ballesta S., Pera G., Pérez-Montes de Oca A., Soldevila B., Caballería L., Morillas R., Expósito C., Martínez–Escudé A., Puig-Domingo M., Franch-Nadal J., Torán P., Cusi K., Julve J., Mauricio D., Alonso N.. Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study. Frontiers in Endocrinology. 2023; 13DOI:10.3389/fendo.2022.1051958. PMID:36714592. IF:3.900(Q2/3D).
01/01/2023 Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Battelino T., Alexander C.M., Amiel S.A., Arreaza-Rubin G., Beck R.W., Bergenstal R.M., Buckingham B.A., Carroll J., Ceriello A., Chow E., Choudhary P., Close K., Danne T., Dutta S., Gabbay R., Garg S., Heverly J., Hirsch I.B., Kader T., Kenney J., Kovatchev B., Laffel L., Maahs D., Mathieu C., Mauricio D., Nimri R., Nishimura R., Scharf M., Del Prato S., Renard E., Rosenstock J., Saboo B., Ueki K., Umpierrez G.E., Weinzimer S.A., Phillip M.. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes & Endocrinology. 2023; 11(1)DOI:10.1016/S2213-8587(22)00319-9. PMID:36493795. IF:44.000(Q1/1D).
01/01/2023 Spanish Consensus on the Use of isCGM in the Management of Patients With Insulin Therapy: The MONITOR Project
Ampudia-Blasco F.J., Ugarte-Abasolo E., Chico A., García-Alemán J., Galan-Barroso M.. Spanish Consensus on the Use of isCGM in the Management of Patients With Insulin Therapy: The MONITOR Project. Journal Of Diabetes Science And Technology. 2023; 17(5)DOI:10.1177/19322968221087270. PMID:35466722. IF:(Q/D).
01/01/2023 Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort
Rojo-López M.I., Bermúdez-López M., Castro E., Farràs C., Torres G., Pamplona R., Lecube A., Valdivielso J.M., Fernández E., Julve J., Castelblanco E., Franch-Nadal J., Alonso N., Granado-Casas M., Mauricio D., Miquel E., Ortega M., Barbé F., González J., Barril S., Sánchez-de-la-Torre M., Portero-Otín M., Jové M., Hernández M., Rius F., Godoy P., Alonso M.M.. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort. ATHEROSCLEROSIS. 2023; 380DOI:10.1016/j.atherosclerosis.2023.117191. PMID:37586219. IF:4.900(Q1/2D).
01/01/2023 Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes
Simo R., Franch-Nadal J., Vlacho B., Real J., Amado E., Flores J., Mata-Cases M., Ortega E., Rigla M., Valles J.-A., Hernandez C., Mauricio D.. Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes. DIABETES CARE. 2023; 46(9)DOI:10.2337/dc22-2521. PMID:37428631. IF:14.800(Q1/1D).
01/01/2023 Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study
Dieberger A.M., Obermayer-Pietsch B., Harreiter J., Desoye G., van Poppel M.N.M., Simmons D., Corcoy R., Perez J.M.A., Kautzky-Willer A., Damm P., Mathiesen E., Jensen D.M., Andersen L.L.T., Dunne F., Lapolla A., Dalfra M.G., Bertolotto A., Jelsma J.G.M., Galjaard S., Wender-Ozegowska E., Zawiejska A., Hill D., Devlieger R., Snoek F.J.. Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study. INTERNATIONAL JOURNAL OF OBESITY. 2023; 47(9)DOI:10.1038/s41366-023-01347-9. PMID:37500924. IF:4.200(Q1/3D).
01/01/2023 Dietary ?3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study
Padro T., López-Yerena A., Pérez A., Vilahur G., Badimon L.. Dietary ?3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study. Nutrients. 2023; 15(16)DOI:10.3390/nu15163637. PMID:37630826. IF:4.800(Q1/2D).
01/01/2023 Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. REVISTA CLINICA ESPANOLA. 2023; 223(7)DOI:10.1016/j.rce.2022.11.001. PMID:37302464. IF:2.300(Q2/3D).